The relationship between serum growth factors and body weight gain was examined in five Dorset lambs. The lambs were weighed and bled by jugular puncture at 2-week intervals between 2 and 18 weeks of age. Somatomedinlike activity (Sm) declined from initially high concentrations at 2 weeks to fairly constant concentrations between 6 and 18 weeks. Relative weight gain-i.e., gain expressed as a percentage of body weight-declined in a manner similar to that of Sm. Mean relative weight gain and mean Sm for the eight 2-week intervals were significantly related (r = .84). Absolute body weight gain-i.e., gain expressed in kilograms-remained fairly constant throughout the study and was not significantly correlated to Sm (r = .15). Serum fibroblast proliferative activity (FPA) was measured as a possible indicator of collective activities of serum growth factors. FPA initially followed a pattern similar to that of Sm, decreasing between 2 and 6 weeks and plateauing until 12 weeks. After 12 weeks, FPA increased to concentrations similar to those observed at 2 weeks. The increase in FPA after 12 weeks was apparently due to an increase in a non-Sin growth factor and had no obvious relationship to body weight changes. Results of the in vitro cell assay system might have been more meaningful if cell type(s) other than WI-38 fibroblasts (e.g., myogenic cells) had been used for estimating collective activities of serum mitogenic factors.
Introduction
Factors which regulate the rate and composition (lean versus fat) of growth in animals are primarily genetic, nutritional, metabolic and hormonal in nature. Improved production of animal protein per unit of feed nutrients may become possible as the specific roles of these factors in growth regulation are understood more completely. Endocrine involvement in the growth processes includes the well-known actions of such hormones as insulin, growth hormone (GH), estrogens and androgens. In recent years, a number of additional serum growth factors have been implicated in the regulation of growth.
Among these is a family of GH-dependent peptides which stimulate sulfate uptake in cartilage and are collectively referred to as somatomedin (Sin) (Van Wyk et al., 1974) . Three similar peptides, called Sm A, B and C, have been isolated from human sera (Van Wyk et al., 1969; Hall and Uthne, 1971; Fryklund et al., 1974a) . Acid-ethanol-soluble nonsuppressible insulin-like activity (NSILA-S) and multiplication stimulating activity (MSA), a peptide isolated from tissue culture media for liver cells, are often classified as Sm (Van Wyk et al., 1974) . Serum Sm was found to be correlated to growth rate in children (Hall and Filipson, 1975) , and Sm C was elevated in swine selected for rate of gain (Lund-Larsen and Bakke, 1975) . Recently, Sm was shown to be positively related to rate of gain and linear growth in Red Danish cattle (Lund-Larsen et al., 1977) . Several other growth factors, such as fibroblast growth factor (FGF) and epidermal growth factor (EGF), have been found to stimu-63 JOURNAL OF ANIMAL SCIENCE, Vol. 52, No. 1, 1981 late growth of cultured cells (Cohen, 1965; Gospodarowicz et al., 1976) . Addition of EGF, FGF and Sm to culture media stimulated growth of cultured human fibroblasts (Carpenter et al., 1975; Fryklund et aL, 1974b; Gospodarowicz and Moran, 1975) . All the growth factors cited have stimulated growth of various types of cultured fibroblasts, and, presumably, fibroblast proliferative activity (FPA) of serum would be a function of the cumulative action of these several mitogenic factors.
The application of cell culture systems to the study of animal growth processes in farm animals is a relatively new approach. In the present study, the assay for FPA of sheep serum was intended to provide an estimate of the collective activities of several serum "growth factors," including Sm. The FPA assay, as an indication of total growth-promoting potential of serum, and Sm-like activity of serum were related to age and body weight gain in sheep. The results revealed that Sm-like activity of serum may be positively related to growth in sheep; even though FPA was not related to growth rate of the sheep, it is possible that the use of other cell types (e.g., myogenic cells) in 6NET-O27X, New England Nuclear, Boston, MA.
Linbro. 8 Clay Adams. the same assay system might have given different results.
Material and Methods
Five Dorset lambs, two intact males and three females, were used. The lambs were penned with their dams and were allowed to nurse. Alfalfa hay was available throughout the study. Lambs were weaned at 12 weeks of age and were fed ad libitum the diet shown in table 1. Body weights were taken at 2-week intervals between 2 and 18 weeks of age. Lambs were weighed and blood samples taken by jugular puncture before the morning feeding, at 0700 hours. Blood was allowed to clot at room temperature and serum was stored at -80 C until assays were performed.
The assay for FPA was based on the uptake of 3H-methyl-thymidine6 by a human lung fibroblast diploid cell line, WI-38. Details of the procedures have been reported (Olsen et aL, 1980) , but the major aspects of the assay are summarized here. The fibroblasts were grown in Eagle's basal medium (BME) supplemented with 10% fetal bovine serum (FBS), penicillin (100 /a/ml) and streptomycin (100 /ag/ml). Fibroblasts were used before passage 35 and were mycoplasma-free. A suspension of 2.25 • 104 cells/ml in 1 ml BME + 10% FBS was added to each of 24 wells of a cell culture tray 7. Each well contained a round coverslip s dAureomycin premix added to provide 22 mg/kg; American Cyanamid, Princeton, NJ.
(13 mm in diameter). Fibroblasts were incubated for 8 hr at 37 C under 2.5% CO2 to allow attachment to coverslips; the medium was then replaced with 1 ml BME + .4% FBS. Incubation under the serum-deficient conditions was continued for 36 hours. These conditions effectively inhibited DNA synthesis. Thymidine incorporation decreased from 6,683 cpm during the 2-hr incubation at the beginning of the serum-depletion period to 256 cpm during the 2-hr incubation at the end of the period. These results are consistent with the "essentially nonmitotic state" maintained for 6 months in human diploid fibroblasts incubated under similar conditions (Dell'Orco, 1974) . On the basis of these data, a 36-hr depletion period was selected. The .4% FCS was chosen to reduce proliferation activity to a basal level (nonmitotic population) to allow the addition of mitogenic factors to stimulate cell growth. After the 36-hr depletion, the medium was replaced with 1 ml BME supplemented with 3% test sera. Incubation was continued for 40 hours. Coverslips were then removed and washed three times each in four trichloroacetic acid (TCA, 5%) and three times in 70% ethanol. The TCA-soluble protein was dissolved in .5 N NaOH and the radioactivity counted in a beta-scintillation counter. This FPA assay system was responsive to various levels of sera. Response in thymidine uptake was fairly linear between 1 and 5% serum and plateaued between 5 and 10% serum. Having established a linear relationship between serum concentration and thymidine incorporation, we selected a serum concentration of 3% for assaying test sera in the studies involving large numbers of serum samples. We believed that at the 3% concentration, test sera would support cell growth, yet have the potential to stimulate thymidine uptake above that found with the 3% normal rat serum. When sufficient amounts of test serum are available and smaller numbers of samples are assayed, it is appropriate to have several dilutions for each test serum; then dose versus response can be determined for each sample. At the concentration of rat serum used (3%), thymidine incorporation increased through 48 hours. An incubation period of 40 hr was selected for the test sera. Even though thymidine incorporation increases rapidly durObtained from New England Nuclear. ing this time, strict adherence to the 40-hr incubation time resulted in low variability of incorporation. The assay was, therefore, responsive to the growth factors in serum that stimulate growth in WI-38 fibroblasts. However, FPA was not increased by direct addition of GH to the medium.
The Sm bioassay was based on sulfate uptake in chick epiphyseal cartilage (Gahagan, 1980) . Chicks were fasted for 2 days and then killed by cervical dislocation. Incisions were made through the hyaline cartilage caps exposing the epiphyseal growth plates at the proximal ends of the tibiotarsus, fibula and tarsometatarsus. The upper portions of the epiphyseal plates were removed and the zone of calcifying cartilage carefully dissected away and discarded. The remaining cartilage was cut into approximately 3 x 3 mm fragments and stored in cold .9% NaCI until used in the bioassay. Single cartilage fragments were incubated in individual 12 x 75 mm tubes. The incubation medium contained 500 /al of an enriched Kreb's phosphosaline buffer. Various amounts of serum and Kreb's phosphosaline buffer were added to provide a total of 950 ttl of medium. The tubes were incubated in a metabolic shaker at 39 C. After 4 hr of incubation, 50/~1 of Kreb's phosphosaline buffer containing 2/aCi of 3s S.sulfate s (specific activity = 894 mCi/mmole) were added to each tube, and incubation was continued for another 3 hours.
The cartilage fragments were then transferred to 12 x 75 mm tubes containing 1 ml distilled water and boiled for 5 minutes. They were rinsed twice in distilled water (.5 hr each), dried, weighed on a Cahn electrobalance and placed in counting vials to which .5 ml formic acid was. added. The vials were placed in a water bath at 95 C for 30 min, after which 10 ml of Triton-X scintillation fluid was added and counts were made. Values were expressed as counts per minute per milligram cartilage weight above buffer control values. All serum samples were taken from individual animals. Each sample was run in quadruplicate at four dilutions-2.5, 5.0, 7.5 and 10.0%.
After plotting log dose response curves, we computed a regression analysis and an index of precision (X) for each serum sample. Average index of precision of the Sm assay was .17. Results are reported in units (U) of sheep Sm activity per milliliter of sera. Pooled sera from five adult sheep was used as a standard in each assay and was assigned 1 U Sm activity. Homo-geneity of regression on the linear portions of the dose response curves was subjected to an F-test to ensure that slopes of dose response curves were similar.
Data were subjected to analysis of variance for a randomized complete block design, with sheep as blocks (Steel and Torrie, 1960) . Means were separated by Duncan's Least Significant Difference test (Wailer and Duncan, 1969) . Relationships between growth factors and body weight gain were examined by simple correlation and regression (Steel and Torrie, 1960) .
Results and Discussion
Serum Sm-like activity decreased (figure 1) between 2 and 6 weeks of age and then remained fairly constant between 6 and 18 weeks. Relative body weight gain-i.e., gain as a percentage of body weight (figure 2)-followed a course similar to that of Sm. Relative gain decreased rapidly between 2 and 6 weeks of age and then plateaued through 12 weeks. It decreased drastically again around weaning (12 weeks) but was restored by 18 weeks of age. Comparison of mean Sm for the five sheep to mean relative gain for the eight 2-week intervals showed the two to be significantly related (r = .84). Regression analysis with individual observations (as opposed to means) resulted in a somewhat lower, though still statistically significant, correlation coefficient (r = .41). Analysis of variance revealed that sheep varied significantly in serum Sm activity but not in relative gain. The significant variation among sheep due to Sm accounted for the lower correlation coefficient obtained from individual observations. Absolute gain-i.e., gain in kilograms-remained fairly constant (.24 -+ .01 kg/day) throughout the study and was not significantly correlated with serum Sm (r = .15).
The importance of Sm in the regulation of growth is well supported. Sm A was positively correlated (r = .67) with growth for a continuum of human subjects ranging from pituitary dwarfs to the unusually tall (Hall and Filipson, 1975) . The role of Sm was supported by reports of elevated GH and low Sm in the Laron dwarf (Kastrup et al., 1975; Pierson et al., 1976) and clinical reports of low GH with normal Sm and continued growth in children (Finkelstein et aL, 1972; Gluckman and Holdaway, 1976) . Sm may also be an important regulator of growth in livestock. Sm C and GH were higher in pigs selected for rate of gain (Lund-Larsen and Bakke, 1975) . Sm was also positively correlated to rate of gain and linear growth in Red Danish bulls (Lund-Larsen et al., 1977) . In this study, gain per unit of body weight was highest for animals with highest serum Sm activities. Together, these results suggest that Sm is associated with the rate of in vivo tissue growth, an association supported by in vitro Sm stimulation of sulfate uptake in cartilage (Van Wyk et al., 1974) and amino acid uptake in the diaphragm of hypophysectomized rats (Uthne, 1973; Uthne et al., 1974) . However, cause-and-effect relationships between serum somatomedin activity and tissue growth in vivo have not been established.
Serum FPA (figure 3) initially followed a course similar to that of Sm, decreasing between 2 and 6 weeks and plateauing through 12 weeks. After 12 weeks of age, FPA increased to a level similar to that observed at 2 weeks. The initial decline and subsequent plateauing of FPA might have been due to decreased Sm. Sm was shown to stimulate growth of WI-38 fibroblasts (Fryklund et aL, 1974b) , and decreased serum Sm would presumably decrease FPA of the serum. The increase in FPA after 12 weeks could not be accounted for by changes in Sin. The increased FPA might have been due to either an increase in non-Sm growth factor or a decrease in a serum inhibitory factor. FGF, EGF and a sialoprotein isolated by Houck and Cheng (1973) are not Sin, and all three stimulate growth in fibroblasts (Carpenter et aL, 1975; Gospodarowicz and Moran, 1975; Houck and Cheng, 1973) . Increases in these growth factors might have been responsible for the increased FPA. On the other hand, corticosteroids were inhibitory to fibroblast growth (Rubin, 1977) , and a decrease in corticosteroids, or some other inhibitory factor, \ ' may also have accounted for increased FPA. Whichever explanation is correct, the increased FPA after 12 weeks of age had no obvious relationship to body weight gain by the lambs. It is important to note the problems as well as the potential of the fibroblast assay used in this study. On the basis of limited data on five sheep and data from a similar study with rats (Olsen et al., 1980) , the FPA assay as described did not distinguish between fast and slow growth rates; i.e., the assay did not detect the higher growth-promoting potential (higher mitogenic factors) of serum from more rapidly growing animals. Further studies are being conducted to clarify this point. In addition, we are testing myogenic cells (L-6) in the assay because such cells may more appropriately reflect activity of target cells responsible for growth in vivo. Our inability to establish a relationship between FPA and body growth may have been due to the fact that the target cells responsible for growth in vivo and the target cells used in the FPA assay (WI-38) have different specificities with respect to the mitogenic factors present in serum. This possibility is supported by the work of Gospodarowicz and Mescher (1977) , who demonstrated specificity in the responsiveness of myogenic cells, fibroblasts and chrondocytes to EGF and FGF.
In summary, serum Sm and relative gain followed similar patterns with increasing age in sheep. Correlation coefficients between body weight and Sm were positive, with the highest coefficient (.84) observed for the correlation between Sm and relative gain. Except for that portion possibly contributed by Sin, FPA had no obvious relationship to body weight gain. The possibility exists that cell types other than WI-38 fibroblasts may be a useful tool for the study of growth regulation.
